{"url_path":"/sec/rgbp/8-k/2026-07-15/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1589150/0001493152-26-033364-index.html","accession_number":"0001493152-26-033364","cik":"0001589150","ticker":"RGBP","issuer_name":"Regen BioPharma Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1589150/0001493152-26-033364-index.html","primary_entity_key":"0001589150","primary_entity_name":"Regen BioPharma Inc"},"word_count":294,"has_tables":true,"body_markdown":"**Item\n8.01 Other Events**\n\n \n\nOn\nJuly 13, 2026 Regen Biopharma Inc. (the “Company”) filed a CERTIFICATE OF DESIGNATION (“Certificate of Designations”)\nwith the Nevada Secretary of State setting forth the preferences rights and limitations of a newly authorized series of preferred stock\ndesignated and known as “Series N Preferred Stock” (hereinafter referred to as “Series N Preferred Stock”).\n\n \n\nThe\nBoard of Directors of the Company have authorized 1,000 shares of the Series N Preferred Stock, par value $0.0001. With respect to each\nmatter submitted to a vote of stockholders of the Corporation, each holder of Series N Preferred Stock shall be entitled to cast that\nnumber of votes which is equivalent to the number of shares of Series N Preferred Stock owned by such holder times seventy five million\n(75,000,000). Except as otherwise required by law holders of Common Stock, other series of Preferred issued by the Corporation, and Series\nN Preferred Stock shall vote as a single class on all matters submitted to the stockholders.\n\n \n\nThe\ndescription of the Certificate of Designations is qualified in its entirety by reference to the full text of the Certificate of Designations,\nwhich is attached hereto as Exhibit 3(i) and incorporated herein by reference.\n\n \n\nThe\nCompany’s Certificate of Incorporation authorizes the Company to issue up to 800,000,000 shares of Preferred Stock, $0.0001 par\nvalue, and grants the Board of Directors of the Company the full authority permitted by law to establish one or more series and the number\nof shares constituting each such series and to fix by resolution full or limited, multiple or fractional, or no voting rights, and such\ndesignations, preferences, qualifications, privileges, limitations, restrictions, options, conversion rights and other special or relative\nrights of any series of the Preferred Stock that may be desired."}